A randomized, double-blind, placebo-controlled Phase 2 trial of evaluating safety and efficacy of different doses and ratios of Cannabis Oil to improve uncontrolled chronic pain in cancer and non-cancer patients
Phase of Trial: Phase II
Latest Information Update: 18 Jun 2018
At a glance
- Drugs Marijuana (Primary)
- Indications Pain
- Focus Therapeutic Use
- 18 Jun 2018 According to a Tetra Bio-Pharma media release, Dr. Antonio Vigano is the Principal Investigator in this trial.
- 18 Jun 2018 According to a Tetra Bio-Pharma media release, status changed from not yet recruiting to recruiting.
- 01 Feb 2018 New trial record